Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma.

Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma. Br J Cancer. 2022 11; 127(8):1497-1506.

View in: PubMed

subject areas

Albumins
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma
Fluorouracil
Head and Neck Neoplasms
Humans
Hydroxyurea
Maximum Tolerated Dose
Neoplasm Recurrence, Local
Paclitaxel
Re-Irradiation

authors with profiles

John Cursio
Daniel J. Haraf
Elizabeth Blair
Nishant Agrawal
Evgeny Izumchenko
Ari Rosenberg
Mark W. Lingen
Everett E. Vokes
Alexander Pearson
Aditya Juloori